Effectiveness of the polysaccharide hemostatic powder in non-variceal upper gastrointestinal bleeding: Using propensity score matching

Jun Chul Park, Yeong Jin Kim, Eun Hye Kim, Jinae Lee, Hyun Su Yang, Eun Hwa Kim, Kyu Yeon Hahn, Sung Kwan Shin, Sang Kil Lee, Yong Chan Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background and Aim: Recently, the application of hemostatic powder to the bleeding site has been used to treat active upper gastrointestinal bleeding (UGIB). We aimed to assess the effectiveness of the polysaccharide hemostatic powder (PHP) in patients with non-variceal UGIB. Methods: We reviewed prospectively collected 40 patients with UGIB treated with PHP therapy between April 2016 and January 2017 (PHP group) and 303 patients with UGIB treated with conventional therapy between April 2012 and October 2014 (conventional therapy group). We compared the rate of successful hemostasis and the rebleeding between the two groups after as well as before propensity score matching using the Glasgow–Blatchford score and Forrest classification. Results: Thirty patients treated with the PHP and 60 patients treated with conventional therapy were included in the matched groups. Baseline patient characteristics including comorbidities, vital signs, and bleeding scores were similar in the matched groups. The rate of immediate hemostasis and 7-day and 30-day rebleeding were also similar in the two groups before and after matching. In the subgroup analysis, no significant differences in immediate hemostasis or rebleeding rate were noted between PHP in monotherapy and PHP combined with a conventional hemostatic method. At 30 days after the therapy, there were no significant PHP-related complications or mortality. Conclusions: Given its safety, the PHP proved feasible for endoscopic treatment of UGIB, having similar effectiveness as that of conventional therapy. The PHP may become a promising hemostatic method for non-variceal UGIB.

Original languageEnglish
Pages (from-to)1500-1506
Number of pages7
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume33
Issue number8
DOIs
Publication statusPublished - 2018 Aug

Fingerprint

Propensity Score
Hemostatics
Powders
Polysaccharides
Hemorrhage
Hemostasis
Research Design
Therapeutics
Vital Signs
Group Psychotherapy
Comorbidity

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Park, Jun Chul ; Kim, Yeong Jin ; Kim, Eun Hye ; Lee, Jinae ; Yang, Hyun Su ; Kim, Eun Hwa ; Hahn, Kyu Yeon ; Shin, Sung Kwan ; Lee, Sang Kil ; Lee, Yong Chan. / Effectiveness of the polysaccharide hemostatic powder in non-variceal upper gastrointestinal bleeding : Using propensity score matching. In: Journal of Gastroenterology and Hepatology (Australia). 2018 ; Vol. 33, No. 8. pp. 1500-1506.
@article{862412b27d924d31999e628be9c2cf11,
title = "Effectiveness of the polysaccharide hemostatic powder in non-variceal upper gastrointestinal bleeding: Using propensity score matching",
abstract = "Background and Aim: Recently, the application of hemostatic powder to the bleeding site has been used to treat active upper gastrointestinal bleeding (UGIB). We aimed to assess the effectiveness of the polysaccharide hemostatic powder (PHP) in patients with non-variceal UGIB. Methods: We reviewed prospectively collected 40 patients with UGIB treated with PHP therapy between April 2016 and January 2017 (PHP group) and 303 patients with UGIB treated with conventional therapy between April 2012 and October 2014 (conventional therapy group). We compared the rate of successful hemostasis and the rebleeding between the two groups after as well as before propensity score matching using the Glasgow–Blatchford score and Forrest classification. Results: Thirty patients treated with the PHP and 60 patients treated with conventional therapy were included in the matched groups. Baseline patient characteristics including comorbidities, vital signs, and bleeding scores were similar in the matched groups. The rate of immediate hemostasis and 7-day and 30-day rebleeding were also similar in the two groups before and after matching. In the subgroup analysis, no significant differences in immediate hemostasis or rebleeding rate were noted between PHP in monotherapy and PHP combined with a conventional hemostatic method. At 30 days after the therapy, there were no significant PHP-related complications or mortality. Conclusions: Given its safety, the PHP proved feasible for endoscopic treatment of UGIB, having similar effectiveness as that of conventional therapy. The PHP may become a promising hemostatic method for non-variceal UGIB.",
author = "Park, {Jun Chul} and Kim, {Yeong Jin} and Kim, {Eun Hye} and Jinae Lee and Yang, {Hyun Su} and Kim, {Eun Hwa} and Hahn, {Kyu Yeon} and Shin, {Sung Kwan} and Lee, {Sang Kil} and Lee, {Yong Chan}",
year = "2018",
month = "8",
doi = "10.1111/jgh.14118",
language = "English",
volume = "33",
pages = "1500--1506",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "8",

}

Effectiveness of the polysaccharide hemostatic powder in non-variceal upper gastrointestinal bleeding : Using propensity score matching. / Park, Jun Chul; Kim, Yeong Jin; Kim, Eun Hye; Lee, Jinae; Yang, Hyun Su; Kim, Eun Hwa; Hahn, Kyu Yeon; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 33, No. 8, 08.2018, p. 1500-1506.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effectiveness of the polysaccharide hemostatic powder in non-variceal upper gastrointestinal bleeding

T2 - Using propensity score matching

AU - Park, Jun Chul

AU - Kim, Yeong Jin

AU - Kim, Eun Hye

AU - Lee, Jinae

AU - Yang, Hyun Su

AU - Kim, Eun Hwa

AU - Hahn, Kyu Yeon

AU - Shin, Sung Kwan

AU - Lee, Sang Kil

AU - Lee, Yong Chan

PY - 2018/8

Y1 - 2018/8

N2 - Background and Aim: Recently, the application of hemostatic powder to the bleeding site has been used to treat active upper gastrointestinal bleeding (UGIB). We aimed to assess the effectiveness of the polysaccharide hemostatic powder (PHP) in patients with non-variceal UGIB. Methods: We reviewed prospectively collected 40 patients with UGIB treated with PHP therapy between April 2016 and January 2017 (PHP group) and 303 patients with UGIB treated with conventional therapy between April 2012 and October 2014 (conventional therapy group). We compared the rate of successful hemostasis and the rebleeding between the two groups after as well as before propensity score matching using the Glasgow–Blatchford score and Forrest classification. Results: Thirty patients treated with the PHP and 60 patients treated with conventional therapy were included in the matched groups. Baseline patient characteristics including comorbidities, vital signs, and bleeding scores were similar in the matched groups. The rate of immediate hemostasis and 7-day and 30-day rebleeding were also similar in the two groups before and after matching. In the subgroup analysis, no significant differences in immediate hemostasis or rebleeding rate were noted between PHP in monotherapy and PHP combined with a conventional hemostatic method. At 30 days after the therapy, there were no significant PHP-related complications or mortality. Conclusions: Given its safety, the PHP proved feasible for endoscopic treatment of UGIB, having similar effectiveness as that of conventional therapy. The PHP may become a promising hemostatic method for non-variceal UGIB.

AB - Background and Aim: Recently, the application of hemostatic powder to the bleeding site has been used to treat active upper gastrointestinal bleeding (UGIB). We aimed to assess the effectiveness of the polysaccharide hemostatic powder (PHP) in patients with non-variceal UGIB. Methods: We reviewed prospectively collected 40 patients with UGIB treated with PHP therapy between April 2016 and January 2017 (PHP group) and 303 patients with UGIB treated with conventional therapy between April 2012 and October 2014 (conventional therapy group). We compared the rate of successful hemostasis and the rebleeding between the two groups after as well as before propensity score matching using the Glasgow–Blatchford score and Forrest classification. Results: Thirty patients treated with the PHP and 60 patients treated with conventional therapy were included in the matched groups. Baseline patient characteristics including comorbidities, vital signs, and bleeding scores were similar in the matched groups. The rate of immediate hemostasis and 7-day and 30-day rebleeding were also similar in the two groups before and after matching. In the subgroup analysis, no significant differences in immediate hemostasis or rebleeding rate were noted between PHP in monotherapy and PHP combined with a conventional hemostatic method. At 30 days after the therapy, there were no significant PHP-related complications or mortality. Conclusions: Given its safety, the PHP proved feasible for endoscopic treatment of UGIB, having similar effectiveness as that of conventional therapy. The PHP may become a promising hemostatic method for non-variceal UGIB.

UR - http://www.scopus.com/inward/record.url?scp=85043343811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043343811&partnerID=8YFLogxK

U2 - 10.1111/jgh.14118

DO - 10.1111/jgh.14118

M3 - Article

C2 - 29415371

AN - SCOPUS:85043343811

VL - 33

SP - 1500

EP - 1506

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 8

ER -